
这个市场不值得进入,结论很明确:已经进入高竞争、接近价格战的状态。 现有数据里,新品牌只有 HOMENURSE 这一家,且它能跑出来的新品只有 1 个,成功率看起来是 100%,但样本只有 1 个,不能当成市场友好证据;反过来,老品牌 Carex 的新品是直接失败的,说明这里不是“谁进来都能赚”,而是必须靠明显差异化、较强预算和更激进的打法才有机会。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这个市场不该进。 目前只能看到少量样本,但信号非常清楚:利润率并不差,可是竞争已经偏向老品牌主导,新品牌的可验证成功案例极少,且没有出现足够多的高质量新入场样本来证明这是一个适合中小卖家稳定切入的市场。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,属于明显的高竞争、接近价格战的市场。 已经出现老牌和新品牌同时靠差异化才能卖出,普通同质化产品直接失利;更关键的是,新品牌只看到1个成功样本,但老品牌新上架样本是0%成功,说明不是“谁进来都能赚”,而是必须靠明显功能创新和更强定价策略。
这个市场不值得进入:样本里只有2个有可比利润数据的新产品,盈利率50%看起来不差,但真正能拿来做生意的只有1个成功案例,失败案例同样是1个,而且成功并不是靠普通小卖家打法。 现有证据显示,能跑出来的只有 HOMENURSE 的 B0GRBLL1BV:售价 63.73 美元,月销 400,月利润 4983.69 美元,毛利率 19.6%,早期投入约 22178.04 美元;而 Carex 的 B0GSVCSK9X、B0D1848QZT 都失败,且失败原因是同质化、竞争挤压、利润空间不足,这不是一个适合小品牌硬闯的环境。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0GRBLL1BV | HOMENURSE | 2026-05-13 | Yes | $63.73 | 400pcs | $25492.0 | 19.55% | $4983.69 |
![]() | B00354B818 | Carex | 2023-09-20 | Yes | $34.49 | 1000pcs | $34490.0 | 10.92% | $3766.31 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0GRBLL1BV | HOMENURSE | 2026-05-13 | Yes | $63.73 | 400pcs | $25492.0 | 19.55% | $4983.69 |
这个市场不值得进入,属于明显的高竞争、偏价格战市场。 现有数据只看到2个品牌:新品牌HOMENURSE 1个新品,利润率19.6%,月销400件、月收入25,492美元、首月/早期投入22,178美元;老品牌Carex有3个产品,仅1个盈利,品牌成功率33.33%,而其新品B0GSVCSK9X直接亏损、无有效销量,说明老牌优势并不稳定,但新进入者要想赢,必须靠明显差异化和足够预算,不是普通跟卖能做成。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这不是一个适合进入的市场。 近一年只看到1个新品牌成功、1个新品牌失败,表面成功率50%,但样本极小,不能说明市场友好;更关键的是,当前真正能跑通的新品是靠明显差异化+低价+白帽投放做出来的,且有$22,178的早期投入,说明不是低成本轻松入场。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |